D. Guertin
Molecular Biology · 2004–2012
A researcher in the Science corpus: 7 papers; trusts 12 researchers and is trusted by 34 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 113 citations into it; #972 of 17,773 by trust here, #884 by citations
- Immunology — 10 citations into it
- Oncology — 9 citations into it
- Pharmacology — 9 citations into it
Whom D. Guertin trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- Dos D. Sarbassov
- Siraj M. Ali
- E. Jacinto
- K. Inoki
- David M. Sabatini
- R. Loewith
- S. Wullschleger
- H. Erdjument‐Bromage
- M. Mueckler
- C. Thoreen
Who trusts D. Guertin overall
- T. Franke
- David M. Sabatini
- M. Laplante
- V. Samuel
- Y. Sancak
- A. Budanov
- B. Manning
- Gerald I. Shulman
- R. A. Saxton
- Arkaitz Carracedo
Papers from D. Guertin's perspective
Ordered by how strongly the researchers D. Guertin trusts endorse each paper. Same corpus, a different order for every researcher.
- Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control. (Molecules and Cells)
- Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex (Science)
- TSC2 mediates cellular energy response to control cell growth and survival. (Cell)
- mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. (Cell)
- Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase. (Proceedings of the National Academy of Sciences of the United States of America)
- Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis. (Cell)
- Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR (Proceedings of the National Academy of Sciences of the United States of America)
- Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. (Current Biology)
- mTOR·RICTOR Is the Ser473 Kinase for Akt/Protein Kinase B in 3T3-L1 Adipocytes* (Journal of Biological Chemistry)
- TOR signaling in growth and metabolism. (Cell)
Their papers
- Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex (2005) — 5,749 citations
- Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. (2004) — 2,819 citations
- Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1. (2006) — 1,535 citations
- Defining the role of mTOR in cancer. (2007) — 2,978 citations
- CellProfiler: image analysis software for identifying and quantifying cell phenotypes (2006) — 5,206 citations
- mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway. (2011) — 1,197 citations
- Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity (2012) — 1,153 citations